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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S292Results: Body weights, blood chemistry and histology of the major organs
showed that the viscosupplement without the TA, and the low and high
dose TA-containing viscosupplement did not result in any systemic
toxicity. The gross analysis of the joint and the synovial ﬂuid showed that
the viscosupplement, with and without the TA, did not result in any local
adverse reaction as determined by gross joint scores, synovial ﬂuid anal-
ysis and cell counts. The differential counts of cells within the synovial
ﬂuid showed that the viscosupplement, with and without the TA, was non-
inﬂammatory. Histological analysis showed that the popliteal lymph nodes
were non-reactive and that the product was well tolerated within the
synovium.
The Safranin O stain depletion score of the Mankin scores (Figure 1)
showed that incorporation of the TA into the hydrogel component of the
viscosupplement resulted in a greater preservation of the proteoglycans in
the joint cartilage as compared to an equivalent bolus dose of the TA. These
differences were statistically signiﬁcant for Hydros-TA(10) compared to
TA(10) at both 28 days and 84 days (p¼0.002 and p¼0.03 respectively) and
for the Hydros-TA(40) compared to TA(40) at 84 days (p¼0.02).
Conclusions: Hydros-TA is biocompatible at 28 days and 84 days following
intra-articular injection into the knee joint of a goat model. Hydros-TA
formulations demonstrated reduced adverse effects on the articular
cartilage as compared to a similar dose of a bolus injection of a TA
suspension. This study demonstrated that the Hydros-TA was safe for
initiating human clinical studies and that incorporation of the corticoste-
roid within the hydrogel component could potentially provide protection
of the cartilage.
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VISCOELASTIC PROPERTIES AND ELASTIC RECOVERY OF HYADD4
HYDROGEL COMPARED TO CROSSLINKED HA-BASED COMMERCIAL
VISCOSUPPLEMENTS
D. Galesso 1, I. Finelli 2, G. Paradossi 2, D. Renier 1. 1 Fidia Farmaceutici SpA,
Abano Terme (PD), Italy; 2 Tor Vergata” Univ., Rome, Italy
Purpose: Viscosupplementation with hyaluronan (HA)-based hydrogels is
used in clinical practice to reduce pain and improve joint function in
osteoarthritis (OA) patients. Rheological properties of intra-articular vis-
cosupplements are fundamental for the quality and duration of mechan-
ical performance. Most of the highly viscoelastic HA-based products are
obtained through crosslinking techniques, causing a strong increase of the
biopolymer molecular weight but raising new issues of biocompatibility
and safety in the clinical environment. HYADD4 (HA partial hex-
adecylamide, contained in Hymovis) is a novel partially hydrophobic
linear (i.e. not chemically crosslinked) HA derivative with lowmodiﬁcation
degree, forming a viscoelastic hydrogel with enhanced intra-articular
residence time and whose clinical safety and effectiveness as visco-
supplement has already been proved. The aim of this study is to compare
the rheological properties of the HYADD4 hydrogel and of somecommercially available crosslinked-HA based viscosupplements, focusing
on the rheological response following mechanical stresses.
Methods: A stress-controlled rheometer was used to study the mechanical
response of the samples in oscillatory shear and in steady shear experi-
ments at 25C. The dynamic viscosity (h) at 1 sec-1 shear rate was deter-
mined, while viscoelasticity was measured in the frequency (u) range of
10-3 to 10 Hz. The recovery of the mechanical properties after a shock was
investigated as a function of time in a single or repeated cycle by oscillatory
measurements at the constant frequency of 1 Hz after destruction of the
gel network. Resistance of the hydrogels to stress was also assessed by
measuring the viscoelastic moduli as a function of increasing stress at
constant frequency.
Results: The dynamic viscosity of the HYADD4 hydrogel is comparable to
that of Synvisc although the former is a linear HA derivative and the latter
is a crosslinked one. Durolane shows the highest viscosity in the same
conditions. Similarly, the viscoelastic moduli G’ and G” of HYADD4 and of
Synvisc are comparable, whereas Durolane is characterized by a higher
viscoelasticity. For all of the three products the elastic modulus G’ is higher
than the viscous modulus G” in almost the whole range of frequency
observed, thus conﬁrming the “gel” character of the samples. When
viscoelasticity is measured after a strong mechanical shock, the elastic
modulus G’ is completely recovered in less than 2 minutes only in
HYADD4. Synvisc and Durolane lose about 30% of their initial elastic
properties, most probably due to the partial cleavage of the chemical
crosslinks of the network. This tendency is conﬁrmed by the analogous
measurement after repeated mechanical stresses, where HYADD4 shows
a constant recovery of elasticity whilst the performance of Synvisc and
Durolane is progressively impaired. Furthermore, HYADD4 shows
a stronger resistance to stress than the two crosslinked HAs, proved by the
constancy of viscoelastic moduli in response to higher forces, probably due
to its less rigid structure.
Conclusions: Although Durolane, due to its more solid-like behavior, is
characterized by a higher viscosity and viscoelasticity than Synvisc and
the HYADD4 hydrogel, HYADD4 shows more favorable features than
both crosslinked HA-based hydrogels in stress-related tests. In fact in the
new hydrogel a strong resistance to stress and a self-healing mechanism
after disruption of the gel structure, given by mechanical shocks, have
been observed. This is very probably due to the chemical structure
differences between rigid crosslinked HAs (Synvisc and Durolane) and
the linear modiﬁcation of HA in HYADD4, that allows for formation of
reversible interactions yielding a gel-like structure. The unique rheological
features of HYADD4 could be potentially useful for the preservation of
viscosupplementation therapy effectiveness in time for active OA patients.
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EFFICACY AND SAFETY OF CONTINUOUS INTRA-ARTICULAR
HYALURONIC ACID INJECTION (HYALGAN) IN TREATMENT OF KNEE
OSTEOARTHRITIS PATIENTS WHO UNDERWENT HIGH TIBIAL
OSTEOTOMY, CLINICAL AND MRI EVALUATION
R. Narkbunnam, K. Chareancholvanich,
C. Pornrattanamaneewong. Mahidol Univ., Bangkok, Thailand
Purpose: Knee osteoarthritis is a disease of progression, causes by dete-
rioration of both mechanical and biochemical factors. High tibial osteot-
omy is one of standard surgical procedure to correct abnormal mechanical
load on the knee joint, whereas, intra-articular hyaluronic acid have
mechanism to restore viscoelastic property of synovial ﬂuid and balance
abnormal biochemical process. Theoretically, combination of these
modalities can create synergistic effect for treatment in knee osteoar-
thritis. This study aimed to evaluate the efﬁcacy and safety of continuous
intra-articular hyaluronic acid injection for treatment in osteoarthritis
knee patients who underwent high tibial osteotomy.
Methods: This study was designed as a randomized, controlled, observer
blinded study method. Forty patients with medial compartmental osteo-
arthritis knee were randomly assigned into control and study groups. The
study group (n¼20) received 2 cycles of 5 intra-articular injection with
sodium hyaluronate (Hyalgan) after high tibial osteotomy operation. The
control group (n¼20) did not receive any intra-articular injection. Treat-
ment efﬁcacies were evaluated by Western Ontario and McMaster
Universities (WOMAC) osteoarthritis index (at 6, 12, 24, 48 weeks after
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Cartilage volume measurements were assessed by Magnetic Resonance
Imaging (MRI) at preoperative period and 1 year after operation.
Results: All patients completed 1 year of study period. After the surgery, all
subscales of WOMAC scores in both groups were signiﬁcantly improved
(p<0.001) when compare to baseline levels. However, there were no
differences between the two groups. Patients who received intra-articular
hyaluronic acid injections had signiﬁcantly reduce the amount of diclofe-
nac consumption (p¼0.017). MRI studies showed signiﬁcantly increase of
the total cartilage volume (p¼0.033), lateral femoral volume (p¼0.044)
and lateral tibial volume (p¼0.027) in the study group compared to the
control group. In addition, loss of lateral tibial plateau cartilage volume
was showed only in the control group. There were no severe adverse
events in both groups.
Conclusion: This study demonstrated positive synergistic effect for using
continuous intra-articular hyaluronic acid injection in patients with oste-
oarthritis of the knee who underwent high tibial osteotomy. Base on our
ﬁnding, intra-articular hyaluronic acid may beneﬁcial to increased total
cartilage volume and prevented the loss of cartilage at lateral tibiofemoral
joint after high tibial osteotomy. Further long term studies with larger
number of patients are warranted.
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EXAMINING THE CYTOKINE PROFILES OF WHOLE BLOOD AND
AUTOLOGOUS PROTEIN SOLUTION OF PATIENTS WITH
OSTEOARTHRITIS: PRELIMINARY RESULTS
K.M. Oshaughnessey 1, J.C. Hoeppner 1, J.E. Woodell-May 1,
C.C. Kaeding 2, C. Lattermann 3, J. Farr, II 4, M.A. Klaassen 5. 1Biomet, Inc.,
Warsaw, IN, USA; 2Ohio State Univ., Columbus, OH, USA; 3Univ. of
Kentucky, Lexington, KY, USA; 4OrthoIndy, Indianapolis, IN, USA;
5Orthopedic and Sports Med. Ctr., Elkhart, IN, USA
Purpose: Recently, anti-cytokine therapy has gainedmomentum as a long-
term treatment solution for osteoarthritis (OA). While a good deal of work
has been done to characterize the cytokine proﬁles of whole blood and
autologous protein solution (APS) from healthy donors, there is very little
literature proﬁling the peripheral blood of OA patients. By performing
cytokine and growth factor analysis on the whole blood and APS of OA
patients, we hope to discover important cytokine interactions as well as
determine the compatibility of an autologous anti-cytokine therapeutic
within an OA patient population. The interactions of cytokines and growth
factors have been analyzed from 60 samples collected thus far in an
ongoing, 105 patient study.
Methods: OA patients were enrolled from 4 sites. From each patient, 60 ml
of blood and a baseline sample were collected. The 60 ml sample was
processed via centrifugation and desiccation to produce APS. The baseline
and APS samples were either shipped in dry ice or personally delivered to
the Biomet Biologics facility where they were frozen at -50C. ELISA was
used to measure the concentration of 13 cytokines and growth factors
(Quantikine kits, R&D Systems). Average concentrations were compared to
published data from healthy donors. Spearman's r correlation was used to
determine signiﬁcant correlation between cytokines. Demographic data
and a KOOS survey was also collected from the patients, and body mass
index (BMI), overall KOOS score, age, and APS volumewere included in the
correlation analysis as well.
Results: Although the growth factor concentrations were lower in the
baseline blood and APS of OA patients, the anti-inﬂammatory cytokine
concentrations were at least as high as those seen from healthy donors
(Fig. 1).
A comparison of baseline and APS cytokine levels revealed some inter-
esting correlation patterns (Fig. 2). EGF, PDGF-AB, PDGF-BB, and TGF-b1
exhibited positive correlationwith each other in both the baseline and APS
samples. This indicates that those four growth factors act in concert and
probably share some of the same pathways. As one might expect, sTNF-RI
and sTNF-RII exhibit a very strong positive correlation, and the APS of both
of these cytokines correlate with TNFa as well. KOOS score exhibited
negative correlation with the baseline concentration of PDGF-AB and TGF-
b1, indicating that patients with higher concentrations of those growth
factors in their peripheral blood responded more positively on the KOOS
survey. BMI exhibited a positive correlation with baseline and APSconcentrations of IL-6, as well as with the APS concentration of sTNF-RI
and sTNF-RII. A positive correlation of IL-6 concentration with BMI reveals
that patients who are more obese are more likely to have a higher
concentration of IL-6 in their circulating blood. This reinforces the
currently held theory that obesity is an inﬂammatory condition.ĂConclusions: In conclusion, there is much that can be learned from the
cytokine and growth factor concentrations of OA patients. The addition of
more patients to this study will lead to even more conclusive evidence of
the various cytokine and growth factor interactions that appear to be
taking place. Additional samples may validate the results obtained to date.
If the current results are conﬁrmed, this data will strengthen the case for
APS as an anti-cytokine therapy and warrant further research of APS for
the treatment of OA.
